Literature DB >> 6285724

Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.

H J Field, B A Larder, G Darby.   

Abstract

A number of clinical studies have documented herpes simplex infections which appear to be resistant to nucleoside analogs; these include idoxuridine [1,2] and acyclovir [3]. Few, if any of the viruses isolated from such patients have yet been thoroughly characterized. We have isolated a number of acyclovir-resistant mutants by selection for resistance in tissue culture. The study of the biochemical and biological properties of these mutants has given some insight into the likely nature of resistant clinical strains. We have devised a number of simple tests to allow classification of laboratory mutants. We also draw attention to some of the difficulties the clinical virologist may encounter when analyzing putative resistant virus isolated from treated patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285724     DOI: 10.1016/0002-9343(82)90124-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models.

Authors:  M Lipsitch; T H Bacon; J J Leary; R Antia; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.

Authors:  S Sakuma; M Yamamoto; Y Kumano; R Mori
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.

Authors:  Jeffry J Leary; Robert Wittrock; Robert T Sarisky; Adriana Weinberg; Myron J Levin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 4.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.